RDY Earnings Results and History
DR Reddys Laboratories Ltd's earnings at a glance: the latest results and outlook from the press release, revenue, margins and EPS for every quarter from the company's SEC filings, and how the stock moved after each report. New results show here within about a minute of being filed.
Year by year
fiscal years, from 10-K filings| Year ended | Revenue | Growth | Op margin | Net income | EPS |
|---|---|---|---|---|---|
| Mar 31, 2025 | $3.81B | +13.8% | 22.1% | $663M | – |
| Mar 31, 2024 | $3.35B | +12.0% | 24.3% | $668M | – |
| Mar 31, 2023 | $2.99B | +5.9% | 23.2% | $548M | – |
| Mar 31, 2022 | $2.83B | +8.9% | 13.8% | $311M | – |
| Mar 31, 2021 | $2.59B | – | 12.8% | $236M | – |
Filings and dates
SEC EDGAR- Jan 22, 2027Next earnings reportexpected
- May 29, 2026Quarterly report20-F All filings
Also see RDY institutional ownership and the earnings calendar.
RDY earnings FAQ
When is RDY's next earnings date?
DR Reddys Laboratories Ltd is expected to report on Jan 22, 2027. Dates can move until the company confirms them.
Where do these numbers come from?
Results, guidance and financials come from DR Reddys Laboratories Ltd's own SEC filings: the earnings press release (Form 8-K) and the quarterly and annual reports (10-Q and 10-K). Key takeaways summarize the press release. Estimates and price moves come from market data.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Results come from company filings with the SEC. Estimates are consensus figures from before each report. Key takeaways summarize the company's press release and may contain errors; the press release is the authoritative source.